Efficacy and safety of Bailing capsules combined with sodium glucose cotransporter inhibitors in diabetic kidney disease treatment

doi:10.4239/wjd.120131

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

(18)

(19)

(0)

(27)

(382)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Diabetes. Jun 15, 2026; 17(6): 120131
Published online Jun 15, 2026. doi: 10.4239/wjd.120131

Full Size Figure Download Figure

Figure 5 Meta-analysis of the effects of Bailing capsules combined with SGLT2is or SGLT2is alone on renal function. A: Sensitivity analysis of serum creatinine (SCr) levels; B: Forest plot of SCr levels; C: Subgroup analysis of SCr levels across different BC dosages; D: Sensitivity analysis of blood urea nitrogen (BUN) levels; E: Forest plot of BUN levels; F: Subgroup analysis of BUN levels across different BC dosages; G: Sensitivity analysis of beta-2 microglobulin (β2-MG) levels; H: Forest plot of β2-MG levels. WMD: Weighted mean difference; SMD: Standardized mean difference.

Citation: Li H, Ren FH, Yang LP, Mao HM, Ma F, Wang YY, Jin Q, Liang PY, Zhan YL. Efficacy and safety of Bailing capsules combined with sodium glucose cotransporter inhibitors in diabetic kidney disease treatment. World J Diabetes 2026; 17(6): 120131
URL: https://www.wjgnet.com/1948-9358/full/v17/i6/120131.htm
DOI: https://dx.doi.org/10.4239/wjd.120131

Li H, Ren FH, Yang LP, Mao HM, Ma F, Wang YY, Jin Q, Liang PY, Zhan YL. Efficacy and safety of Bailing capsules combined with sodium glucose cotransporter inhibitors in diabetic kidney disease treatment. World J Diabetes 2026; 17(6): 120131 [DOI: 10.4239/wjd.120131]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.